IDEAYA Biosciences, Inc. (IDYA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.06B |
| Enterprise Value | 2.97B |
| P/E Ratio | -23.41 |
| PEG Ratio | -0.53 |
| Price/Sales Ratio | 15.61 |
| Price/Book Ratio | 3.5 |
| Enterprise/Revenue | 15.04 |
| Enterprise/EBITDA | -25.01 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.62 |
| Operating Margin | -0.81 |
| Return On Assets | -0.14 |
| Return On Equity | -0.14 |
| Revenue | 218.71M |
| Revenue/Share | 2.54 |
| Gross Profit | 214.12M |
| EBITDA | -109.11M |
| Net Income | -113.7M |
| Diluted EPS | -1.28 |
| Total Cash | 671.2M |
| Total Cash/Share | 7.57 |
| Total Debt | 28.6M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 10.74 |
| Book Value Per Share | 10.57 |
| 52-Week Change | 63.82 |
| 52-Week High | 40.58 |
| 52-Week Low | 21.33 |
| Moving Average 50 Days | 31.24 |
| Moving Average 200 Days | 32.05 |
| Average Volume | 1.38M |
| Shares Outstanding | 95.08M |
| % Held by Institutions | 107.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |